16-71947527-TTC-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_181536.2(PKD1L3):c.3681_3682delGA(p.Asn1228fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0015 in 1,546,568 control chromosomes in the GnomAD database, including 33 homozygotes. Variant has been reported in ClinVar as Benign (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.0081 ( 18 hom., cov: 32)
Exomes 𝑓: 0.00078 ( 15 hom. )
Consequence
PKD1L3
NM_181536.2 frameshift
NM_181536.2 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.75
Genes affected
PKD1L3 (HGNC:21716): (polycystin 1 like 3, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded protein contains 11 transmembrane domains, a latrophilin/CL-1-like GPCR proteolytic site (GPS) domain, and a polycystin-1, lipoxygenase, alpha-toxin (PLAT) domain. This protein may function as a component of cation channel pores.[provided by RefSeq, Apr 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP6
Variant 16-71947527-TTC-T is Benign according to our data. Variant chr16-71947527-TTC-T is described in ClinVar as [Benign]. Clinvar id is 770635.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00807 (1228/152252) while in subpopulation AFR AF = 0.028 (1161/41516). AF 95% confidence interval is 0.0266. There are 18 homozygotes in GnomAd4. There are 562 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position FAILED quality control check.
BS2
High Homozygotes in GnomAd4 at 18 gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00805 AC: 1225AN: 152134Hom.: 18 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1225
AN:
152134
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000369 AC: 58AN: 156978 AF XY: 0.000289 show subpopulations
GnomAD2 exomes
AF:
AC:
58
AN:
156978
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000781 AC: 1089AN: 1394316Hom.: 15 AF XY: 0.000680 AC XY: 468AN XY: 688022 show subpopulations
GnomAD4 exome
AF:
AC:
1089
AN:
1394316
Hom.:
AF XY:
AC XY:
468
AN XY:
688022
Gnomad4 AFR exome
AF:
AC:
882
AN:
31474
Gnomad4 AMR exome
AF:
AC:
62
AN:
35696
Gnomad4 ASJ exome
AF:
AC:
0
AN:
25152
Gnomad4 EAS exome
AF:
AC:
0
AN:
35710
Gnomad4 SAS exome
AF:
AC:
7
AN:
79106
Gnomad4 FIN exome
AF:
AC:
0
AN:
49136
Gnomad4 NFE exome
AF:
AC:
14
AN:
1074466
Gnomad4 Remaining exome
AF:
AC:
117
AN:
57882
Heterozygous variant carriers
0
52
104
156
208
260
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00807 AC: 1228AN: 152252Hom.: 18 Cov.: 32 AF XY: 0.00755 AC XY: 562AN XY: 74452 show subpopulations
GnomAD4 genome
AF:
AC:
1228
AN:
152252
Hom.:
Cov.:
32
AF XY:
AC XY:
562
AN XY:
74452
Gnomad4 AFR
AF:
AC:
0.0279651
AN:
0.0279651
Gnomad4 AMR
AF:
AC:
0.00340003
AN:
0.00340003
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.0000882068
AN:
0.0000882068
Gnomad4 OTH
AF:
AC:
0.00378072
AN:
0.00378072
Heterozygous variant carriers
0
59
117
176
234
293
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
May 29, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at